Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS

2014151 citationsJournal Articlebronze Open Access

Authors

The immune response induced by this vaccine may improve the prognosis of patients with advanced HNSCC.

Good health and well-being

Published in: Clinical Cancer Research

Volume 21, Issue 2, pp. 312-321

Field-Weighted Citation Impact: 5.97